Global Engagement Council Leadership
-
Special Interest Groups
- Biosimilars
- Clinical Outcome Assessment
- Digital Health
- Health Preference Research
- Medical Devices and Diagnostics
-
Medication Adherence and Persistence
-
Nutrition Economics
- Oncology
- Open Source Models
- Patient-Centered
- Precision Medicine and Advanced Therapies
- Rare Disease
- Real-World Evidence (RWE)
- Statistical Methods in HEOR
-
Task Forces
- Consolidated Health Economic Evaluation Reporting Standards (CHEERS) II
- Joint HTAi - ISPOR Deliberative Processes for HTA
- Machine Learning Methods in HEOR
-
Measurement Comparability Between Modes of Administration of PROMs
- Measuring Patient Preferences for Decision Making
- Performance Outcome (PerfO) Assessments
- Systematic Reviews with Cost and Cost-Effectiveness Outcomes
- Joint ISPE-ISPOR Special Task Force
- Councils & Roundtables
- Global Groups
- Students
-
New Professionals
-
Professional Development Resources
- What is the Impact of GDPR on the HEOR Community
- Good Practices for HTA - What is out there and how do I use it
- ISPOR & AACP Joint Webinar – “Tips for Securing a Post-Doctoral Fellowship”
- You Are Creative: Research is the First Step
- AMCP eDossier System @ FormularyDecisions.com Demo and Practical Application
- Good Practices for a Successful Job Search
- Leveraging The Power Of LinkedIn
- Internships & Fellowships: Career Opportunities for the Future
- My Career Path
- Career Advice Across the Globe
- "My ISPOR Story" - Zeba Khan
- "My ISPOR Story" - Lou Garrison
- Replicate, Regulate, and Redefine: RWE Use Cases in the Next Decade - Session 1
- Replicate, Regulate, and Redefine: RWE Use Cases in the Next Decade - Session 2
- Replicate, Regulate, and Redefine: RWE Use Cases in the Next Decade - Session 3
-
Professional Development Resources
Council Chair
Mahmoud Elmahdawy, PharmD
Director, Market Access and Health Economics, Novartis Lecturer of Clinical and Hospital Pharmacy, Misr International University, Cairo, Egypt
Asia Consortium Chair
Kun Zhao, MD, PhD, MHSc
Professor & Director, Division of Health Policy Evaluation and Technology Assessment, China National Health Development Research Center, National Health Commission, Beijing, China
CEE Network Chair
Guenka Ivanova Petrova, MPharm, MEcon, PhD, DSc
Medical University of Sofia, Sofia, Bulgaria
Africa Network Chair
Mohammed Lamorde, HBBS, MRCP, PHD
Head of Department, Prevention, Care and Treatment Programme, Infectious Diseases Institute (IDI) Makerere University College of Health Sciences Kampala, Uganda
President, Italy-Rome Chapter
Alberto Migliore, MD
Director, Chief Rheumatology Unit, San Pietro Hospital, Rome, Italy
President, Spain Chapter
Carme Pinyol, MD, MSc
Founder and Director, INNOVA-Strategic Consulting, Barcelona, Spain
President, Boston Chapter
Brian Rittenhouse
Associate Professor of Social and Administrative Sciences, Massachusetts College of Pharmacy and Health Sciences (MCPHS) University, Boston, MA, USA
Governance Committee Chair
Adrian Towse, MA, MPhil
Director, Office of Health Economics (OHE), and Visiting Professor, London School of Economics, London, UK
Latin America Global Engagement Council Representative
Rosa Maria Galindo-Suarez,
MHE Prioritization Deputy Director General Health Council Mexico City, Mexico.
Arabic Network Chair
Ola Ghaleb Alahdab, PhD
Pharmaceutical Advisor, CPD-Pharma Program Manager Registration and Drug Control Department, Ministry of Health Abu Dhabi, UAE
President, Italy-Milan Chapter
Lorenzo Mantovani
Associate Professor of Public Health, University of Milan, Bicocca, Milan, Italy
President, Portugal Chapter
Miguel Gouveia, PhD
Associate Professor, School of Business and Economics, The Catholic University of Portugal (UCP), Lisbon, Portugal
President, Austria Chapter
Beate Jahn, PhD
Assistant Professor, UMIT – University for Health Sciences, Medical Informatics and Technology Tyrol, Austria
Midwest Regional Chapter
Gebra Cuyun Carter, MPH, PhD
Research Scientist Eli Lilly & Company Columbus, OH, USA